BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 16828834)

  • 21. Stable integration of recombinant adeno-associated virus vector genomes after transduction of murine hematopoietic stem cells.
    Han Z; Zhong L; Maina N; Hu Z; Li X; Chouthai NS; Bischof D; Weigel-Van Aken KA; Slayton WB; Yoder MC; Srivastava A
    Hum Gene Ther; 2008 Mar; 19(3):267-78. PubMed ID: 18303957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction.
    Hauck B; Zhao W; High K; Xiao W
    J Virol; 2004 Dec; 78(24):13678-86. PubMed ID: 15564477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo.
    Qing K; Khuntirat B; Mah C; Kube DM; Wang XS; Ponnazhagan S; Zhou S; Dwarki VJ; Yoder MC; Srivastava A
    J Virol; 1998 Feb; 72(2):1593-9. PubMed ID: 9445062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction.
    Sipo I; Fechner H; Pinkert S; Suckau L; Wang X; Weger S; Poller W
    Gene Ther; 2007 Sep; 14(18):1319-29. PubMed ID: 17611587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation.
    Douar AM; Poulard K; Stockholm D; Danos O
    J Virol; 2001 Feb; 75(4):1824-33. PubMed ID: 11160681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syntaxin 5-dependent retrograde transport to the trans-Golgi network is required for adeno-associated virus transduction.
    Nonnenmacher ME; Cintrat JC; Gillet D; Weber T
    J Virol; 2015 Feb; 89(3):1673-87. PubMed ID: 25410859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses.
    Zhong L; Li B; Mah CS; Govindasamy L; Agbandje-McKenna M; Cooper M; Herzog RW; Zolotukhin I; Warrington KH; Weigel-Van Aken KA; Hobbs JA; Zolotukhin S; Muzyczka N; Srivastava A
    Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7827-32. PubMed ID: 18511559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection of purified nuclei by adeno-associated virus 2.
    Hansen J; Qing K; Srivastava A
    Mol Ther; 2001 Oct; 4(4):289-96. PubMed ID: 11592830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8.
    Natkunarajah M; Trittibach P; McIntosh J; Duran Y; Barker SE; Smith AJ; Nathwani AC; Ali RR
    Gene Ther; 2008 Mar; 15(6):463-7. PubMed ID: 18004402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic stability of self-complementary adeno-associated virus 2 during early stages of transduction in mouse muscle in vivo.
    Ren C; Kumar S; Shaw DR; Ponnazhagan S
    Hum Gene Ther; 2005 Sep; 16(9):1047-57. PubMed ID: 16149903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively than adenoviral vectors.
    Enger PØ; Thorsen F; Lønning PE; Bjerkvig R; Hoover F
    Hum Gene Ther; 2002 Jun; 13(9):1115-25. PubMed ID: 12067444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency.
    Hacker UT; Wingenfeld L; Kofler DM; Schuhmann NK; Lutz S; Herold T; King SB; Gerner FM; Perabo L; Rabinowitz J; McCarty DM; Samulski RJ; Hallek M; Büning H
    J Gene Med; 2005 Nov; 7(11):1429-38. PubMed ID: 15945124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking.
    Lux K; Goerlitz N; Schlemminger S; Perabo L; Goldnau D; Endell J; Leike K; Kofler DM; Finke S; Hallek M; Büning H
    J Virol; 2005 Sep; 79(18):11776-87. PubMed ID: 16140755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo.
    McCarty DM; Fu H; Monahan PE; Toulson CE; Naik P; Samulski RJ
    Gene Ther; 2003 Dec; 10(26):2112-8. PubMed ID: 14625565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors.
    Ferrari FK; Samulski T; Shenk T; Samulski RJ
    J Virol; 1996 May; 70(5):3227-34. PubMed ID: 8627803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of recombinant adeno-associated viral vectors for human beta-globin gene transfer and transgene expression.
    Maina N; Zhong L; Li X; Zhao W; Han Z; Bischof D; Aslanidi G; Zolotukhin S; Weigel-Van Aken KA; Rivers AE; Slayton WB; Yoder MC; Srivastava A
    Hum Gene Ther; 2008 Apr; 19(4):365-75. PubMed ID: 18399730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines.
    Markusic DM; Herzog RW; Aslanidi GV; Hoffman BE; Li B; Li M; Jayandharan GR; Ling C; Zolotukhin I; Ma W; Zolotukhin S; Srivastava A; Zhong L
    Mol Ther; 2010 Dec; 18(12):2048-56. PubMed ID: 20736929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Site-Directed Mutagenesis of Surface-Exposed Lysine Residues Leads to Improved Transduction by AAV2, But Not AAV8, Vectors in Murine Hepatocytes In Vivo.
    Li B; Ma W; Ling C; Van Vliet K; Huang LY; Agbandje-McKenna M; Srivastava A; Aslanidi GV
    Hum Gene Ther Methods; 2015 Dec; 26(6):211-20. PubMed ID: 26421998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.